<DOC>
	<DOCNO>NCT01405157</DOCNO>
	<brief_summary>A study determine whether new formulation methylprednisolone suspension bioequivalent methylprednisolone tablet fast condition .</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Healthy male female subject age 21 55 year . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 total body weight &gt; 45 kg ( 99 lb ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive uring drug screen .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>bioequivalence study</keyword>
	<keyword>methylprednisolone</keyword>
	<keyword>suspension</keyword>
	<keyword>tablet</keyword>
	<keyword>fast</keyword>
</DOC>